Cargando…
Targeting p53 pathways: mechanisms, structures, and advances in therapy
The TP53 tumor suppressor is the most frequently altered gene in human cancers, and has been a major focus of oncology research. The p53 protein is a transcription factor that can activate the expression of multiple target genes and plays critical roles in regulating cell cycle, apoptosis, and genom...
Autores principales: | Wang, Haolan, Guo, Ming, Wei, Hudie, Chen, Yongheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977964/ https://www.ncbi.nlm.nih.gov/pubmed/36859359 http://dx.doi.org/10.1038/s41392-023-01347-1 |
Ejemplares similares
-
Targeting MCL-1 in cancer: current status and perspectives
por: Wang, Haolan, et al.
Publicado: (2021) -
Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
por: Wei, Hudie, et al.
Publicado: (2023) -
Structural basis of the specificity and interaction mechanism of Bmf binding to pro-survival Bcl-2 family proteins
por: Wang, Haolan, et al.
Publicado: (2023) -
Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis
por: Wei, Hudie, et al.
Publicado: (2021) -
p53 amyloid aggregation in cancer: function, mechanism, and therapy
por: Li, Jingzhi, et al.
Publicado: (2022)